FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

THEMISMED

406.2
+22.35 (5.82%)
Updated 03:28 13/07 IST

THEMISMED Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for THEMISMED
Disclaimer
0% Bullish
0% Bearish

THEMISMED Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See THEMISMED Share Price Targets >>

THEMISMED Ratings

Long term THEMISMED rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live THEMISMED message board: Is THEMISMED buy or sell? Should I buy THEMISMED shares? Why are THEMISMED shares falling? Should I invest in THEMISMED stock?

  1. Home
  2. THEMISMED Forum

THEMISMED Share Price Discussion

N
Reputation: 3,388 • Jul 10, 2019 12:23 PM
Like
Reply
N
Reputation: 3,388 • Jul 8, 2019 11:23 AM
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • THEMISMED - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization272.14
    Enterprise Value344.93
    Price to Earnings54.95
    Price to Book Value1.9
    Return on Capital Employed0.11
    Return on Equity0.08
    Face Value10
    Dividend YieldNA
  • THEMISMED Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 13380411.7380405.4
    Jul 10375387.7369.95383.85
    Jul 9374.3375359.6374.5
    Jul 8350375350366.2
    Jul 7350367349.3355.7
  • THEMISMED Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹350.41
    30 Day Moving Average₹339.39
    50 Day Moving Average₹320.96
    100 Day Moving Average₹296.01
    200 Day Moving Average₹255.75
  • THEMISMED - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue209.51216.66-0.03
    Operating Profit25.6431.89-0.2
    Profit Before Tax9.417-0.45
    Net Income9.2917.54-0.47
  • THEMISMED - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds143.34120.260.19
    Total Liabilities155.99192.88-0.19
    Total Assets299.33313.14-0.04
  • THEMISMED - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity7.83-12.15-1.64
    Cash from Investing Activity-0.03-4.09-0.99
    Cash from Financing Activity-9.1120.77-1.44
    Net Cash Flow-1.34.53-1.29
  • THEMISMED - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.07
    Return on Equity0.080.16
    Return on Capital Employed0.110.15
  • THEMISMED - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.26
    3 Year CAGR Growth in Operating Profit1.35
    3 Year CAGR Growth in EBIDTA0.23
    3 Year CAGR Growth in Net Income3.53
    3 Yr CAGR Growth - Diluted EPS3.15
  • THEMISMED - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.41
    5 Year CAGR Growth in Operating Profit1.79
    5 Year CAGR Growth in EBIDTA1.3
    5 Year CAGR Growth in Net Income2.14
    3 Yr CAGR Growth - Diluted EPS2
  • THEMISMED - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 10, 2019 12:23 PM
    NewsBot
    Jul 8, 2019 11:23 AM
  • THEMISMED - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020